Assembly Biosciences (ASMB) Change in Acquisitions & Divestments (2015 - 2026)

Assembly Biosciences' Change in Acquisitions & Divestments history runs 12 years deep, the most recent figure standing at $57.6 million for Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments rose 117.92% year-over-year to $57.6 million in Q1 2026; TTM through Mar 2026 was $147.6 million, a 8.42% increase from a year earlier, with the FY2025 full-year figure at $116.4 million, down 10.92% from the prior year.
• Change in Acquisitions & Divestments climbed to $57.6 million in Q1 2026 per ASMB's latest filing, from $32.8 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $57.6 million in Q1 2026 and bottomed at -$37.2 million in Q4 2022.
• The 5-year median for Change in Acquisitions & Divestments is $22.7 million (2025), against an average of $23.4 million.
• Across the five-year window, Change in Acquisitions & Divestments sank 186.45% in 2022 and soared 150.3% in 2023, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at -$37.2 million in 2022, then surged by 150.3% to $18.7 million in 2023, then jumped by 82.89% to $34.2 million in 2024, then slipped by 4.09% to $32.8 million in 2025, then surged by 75.61% to $57.6 million in 2026.
• Per Business Quant, the three latest ASMB Change in Acquisitions & Divestments figures stand at $57.6 million (Q1 2026), $32.8 million (Q4 2025), and $22.7 million (Q3 2025).